Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Leclercq

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Hepatology (Baltimore, Md.)|March 25, 2006
COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediatorJun Yu, Emilia Ip, Aileen Dela Peña, et al.
Hepatology Communications|July 24, 2019
Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and FibrosisPeter Stärkel, Bernd Schnabl, Sophie Leclercq, et al.
Journal of Hepatology|February 23, 2019
Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injuryRita Manco, Laure-Alix Clerbaux, Stefaan Verhulst, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 24, 2017
Liver and systemic hemodynamics in children with cirrhosis: Impact on the surgical management in pediatric living donor liver transplantationCatherine de Magnée, Francis Veyckemans, Thierry Pirotte, et al.
Clinical Science (London, England : 1979)|September 22, 2021
Selective HIF stabilization alleviates hepatocellular steatosis and ballooning in a rodent model of 70% liver resectionSamuele Iesari, Isabelle Leclercq, Nicolas Joudiou, et al.
Archives of Toxicology|June 7, 2015
Experimental models of liver fibrosisSara Crespo Yanguas, Bruno Cogliati, Joost Willebrords, et al.
Hepatology (Baltimore, Md.)|January 10, 2013
Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent modelsStephanie Coulon, Vanessa Legry, Femke Heindryckx, et al.
Cells|May 24, 2020
Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid MetabolismCharlotte Lefort, Martin Roumain, Matthias Van Hul, et al.
Bioactive Materials|June 8, 2026
Engineered protein nanoclusters reduce liver fibrosis and hepatocellular carcinoma in mice modelsTanya Saxena, Gabriela Guedes, Inês Domingues, et al.
International Journal of Molecular Sciences|March 15, 2018
TAT-Gap19 and Carbenoxolone Alleviate Liver Fibrosis in MiceSara Crespo Yanguas, Tereza C da Silva, Isabel V A Pereira, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|March 25, 2006
COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediatorJun Yu, Emilia Ip, Aileen Dela Peña, et al.
Hepatology Communications|July 24, 2019
Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and FibrosisPeter Stärkel, Bernd Schnabl, Sophie Leclercq, et al.
Journal of Hepatology|February 23, 2019
Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injuryRita Manco, Laure-Alix Clerbaux, Stefaan Verhulst, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 24, 2017
Liver and systemic hemodynamics in children with cirrhosis: Impact on the surgical management in pediatric living donor liver transplantationCatherine de Magnée, Francis Veyckemans, Thierry Pirotte, et al.
Clinical Science (London, England : 1979)|September 22, 2021
Selective HIF stabilization alleviates hepatocellular steatosis and ballooning in a rodent model of 70% liver resectionSamuele Iesari, Isabelle Leclercq, Nicolas Joudiou, et al.
Archives of Toxicology|June 7, 2015
Experimental models of liver fibrosisSara Crespo Yanguas, Bruno Cogliati, Joost Willebrords, et al.
Hepatology (Baltimore, Md.)|January 10, 2013
Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent modelsStephanie Coulon, Vanessa Legry, Femke Heindryckx, et al.
Cells|May 24, 2020
Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid MetabolismCharlotte Lefort, Martin Roumain, Matthias Van Hul, et al.
Bioactive Materials|June 8, 2026
Engineered protein nanoclusters reduce liver fibrosis and hepatocellular carcinoma in mice modelsTanya Saxena, Gabriela Guedes, Inês Domingues, et al.
International Journal of Molecular Sciences|March 15, 2018
TAT-Gap19 and Carbenoxolone Alleviate Liver Fibrosis in MiceSara Crespo Yanguas, Tereza C da Silva, Isabel V A Pereira, et al.
Pageof 6